Regulation #16A-5431: Naloxone Exceptions
Provides expanded access to the overdose-reversing drug, Naloxone, to at-risk individuals who are pending discharge or release from correctional facilities, prisons, jails and residential drug treatment facilities.
IRRC Number |
3218 |
Proposed Regulation Received |
|
Agency Name |
State Board of Pharmacy |
PA Bulletin Publish Date |
|
Regulation Status |
Final-Omitted |
Close of Public Comment |
|
PA Code |
49 Pa. Code
Chapter 27
|
Final Due By |
|
Analysts Assigned |
Corinne R. Brandt (CRB)
Fiona E. Cormack (FEC)
|
IRRC Comments Due |
|
Final-Omitted
Regulation Received
|
October 10, 2018
|
Public Meeting Date |
November 15, 2018
|
Published as Final |
December 01, 2018
|
Actions Taken |
|
IRRC Approval |
November 15, 2018 |
House Committee Deems Regulation Approved |
November 14, 2018 |
Senate Committee Deems Regulation Approved |
November 14, 2018 |
LOADING...
Proposed regulation has not yet been submitted.
|
Public Comments on Proposed Regulation
|
There are currently no public comments on the proposed regulation.
|
|
Legislative Comments (on the Proposed and Final Regulation)
|
There are currently no legislative comments on the proposed or final regulation.
|
|
IRRC Comments on Proposed Regulation
|
There are currently no IRRC comments on the proposed regulation.
|
|
|
|
Public Comments on Final Regulation
|
There are currently no public comments on the final regulation.
|
|
Legislative Comments (on the Proposed and Final Regulation)
|
There are currently no legislative comments on the proposed or final regulation.
|
|
|
APPROVAL |
November 15, 2018 |
|
In addition to comments, IRRC occasionally receives other correspondence and written materials from state agencies and the legislature regarding pending regulations. These documents can be found on this portion of our website.
There are currently no related documents.
|